For: | Hammer L, Furtado S, Mathiowitz E, Auci DL. Oral encapsulated transforming growth factor β1 reduces endogenous levels: Effect on inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2020; 11(5): 79-92 [PMID: 33251033 DOI: 10.4292/wjgpt.v11.i5.79] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v11/i5/79.htm |
Number | Citing Articles |
1 |
Piotr Morasiewicz, Monika Zaborska, Michał Sobczak, Łukasz Tomczyk, Paweł Leyko, Andrzej Bobiński, Joanna Kochańska-Bieri, Daniele Pili, Krystian Kazubski. The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures. Pharmaceuticals 2024; 17(11): 1531 doi: 10.3390/ph17111531
|
2 |
Margaret Bohmer, Yonger Xue, Katarina Jankovic, Yizhou Dong. Advances in engineering and delivery strategies for cytokine immunotherapy. Expert Opinion on Drug Delivery 2023; 20(5): 579 doi: 10.1080/17425247.2023.2208344
|
3 |
Piotr Morasiewicz, Monika Zaborska, Michał Sobczak, Łukasz Tomczyk, Daniele Pili, Krystian Kazubski, Paweł Leyko. The Use of Ossein–Hydroxyapatite Complex in Conjunction with the Ilizarov Method in the Treatment of Tibial Nonunion. Journal of Clinical Medicine 2025; 14(10): 3353 doi: 10.3390/jcm14103353
|
4 |
Ye Liu, Jinjian Huang, Sicheng Li, Ze Li, Canwen Chen, Guiwen Qu, Kang Chen, Yitian Teng, Rui Ma, Xiuwen Wu, Jianan Ren. Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review. Biomaterials Science 2024; 12(4): 837 doi: 10.1039/D3BM01645E
|
5 |
Nasim Hatamzade Esfahani, Andrew S. Day. The Role of TGF-β, Activin and Follistatin in Inflammatory Bowel Disease. Gastrointestinal Disorders 2023; 5(2): 167 doi: 10.3390/gidisord5020015
|
6 |
Ferdinando Nicoletti, Laura Hammer, Stacia Furtado, Katia Mangano, Edith Mathiowitz, Benjamin Green, Dominick L Auci. Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis. Inflammatory Bowel Diseases 2022; 28(3): 455 doi: 10.1093/ibd/izab204
|